Atrium Therapeutics, Inc. (RNA)
NASDAQ · Manufacturing · Pharmaceutical preparations
RNA price, last 12 months
Key stats
- Previous close
- $6.64
- Open
- $6.70
- Day range
- $6.65 – $7.13
- 52-week range
- $6.36 – $16.77
- Volume
- 225.9K
- Avg volume (20 days)
- 236.5K
- Market cap
- $162.0M
Performance
Technicals and fundamentals
About Atrium Therapeutics, Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $162.0M